Inactive Instrument

Aceto Corporation

Aceto Corp. Appoints Satish Srinivasan as President and Chief Operating Officer of its Rising Pharmaceuticals subsidiary, Effective July 15, 2013

June 13, 2013 at 02:00 pm

Aceto Corp. announced that Satish Srinivasan has accepted the position of President and Chief Operating Officer of its Rising Pharmaceuticals subsidiary, effective July 15, 2013. Satish has nearly twenty years of experience in the generic pharmaceutical industry, all with Orchid Chemicals & Pharmaceuticals Ltd. Over the years, he has held various business development, operating and management roles, serving most recently as the President and CEO of Orchid Pharma Inc. and Orgenus Pharma Inc, the U.S. operating subsidiaries of OCP.

Latest news about Aceto Corporation

Actylis and Novo Nordisk Pharmatech Announce a Strategic Partnership for the Distribution of Benzalkonium Chloride in Targeted European Countries	03-25	CI
Actylis Launches A New Cgmp Wfi Generation, Storage, and Distribution System with Additional Iso Class 7 Manufacturing Space	23-09-21	CI
Actylis Opens a 30,000Ft² cGMP Facility to Bolster its Innovative Api Manufacturing Capabilities	23-02-27	CI
Aceto Corporation acquired Talus Mineral Company and Biotron Laboratories, Inc.	22-03-01	CI
Aceto Corporation acquired A & C Bio Buffer Limited.	21-10-11	CI
Aceto Corporation acquired Cascade Chemistry.	21-06-01	CI
Aceto Corporation acquired an unknown majority stake in Finar Ltd.	21-05-16	CI
Aceto Strengthens Self-Manufacturing and Vaccine and Biopharmaceutical Offering with Acquisition of A&C	21-04-15	CI
Aceto Corporation acquired A&C.	21-04-14	CI
Aceto to Expand Bioreagent Offering to Support Growing Customer Demand in Biopharma and Cell Culture Manufacturing	21-03-15	CI
Aceto Corporation acquired IsleChem, LLC.	20-12-20	CI
Aceto Corporation's Equity Buyback announced on December 11, 2009, has expired.	20-05-30	CI
Aceto Corporation completed the acquisition of Syntor Fine Chemicals Limited.	20-04-16	CI
Aceto Corporation agreed to acquire Syntor Fine Chemicals Limited.	20-04-05	CI
Aceto Corporation Went Out of Business	19-10-01	CI
Second Motion for Exclusivity Period Extension Approved For Aceto Corporation	19-09-20	CI
Second Modified Joint Liquidation Plan and Disclosure Statement Approved for Aceto Corporation	19-09-18	CI
Motion for Asset Sale Approved for Aceto Corporation	19-09-04	CI
Motion for Asset Sale Filed by Aceto Corporation	19-08-12	CI
Disclosure Statement Approved on Interim Basis for Aceto Corporation	19-07-26	CI
Aceto Announces Management Changes	19-06-20	CI
Aceto Corporation Announces Executive Changes	19-06-18	CI
First Motion for Exclusivity Period Extension Approved For Aceto Corporation	19-06-18	CI
Joint Liquidation Plan and Disclosure Statement Filed by Aceto Corporation	19-06-17	CI
Aceto Corporation Announces the Termination of William C. Kennally, III as President and Chief Executive Officer of the Company	19-06-03	CI

Chart Aceto Corporation

Duration

Period

More charts

Company Profile

Tri Harbor Holdings Corp., also known as Aceto, is a United States-based virtual manufacturer engaged in supplying specialty materials. The Company is primarily engaged in supplying its materials to life sciences and advanced technology end markets. The Company operates its business operations in nine countries, and distributes over 1,100 chemical compounds used principally by the pharmaceutical, nutraceutical, agricultural, and specialty chemical industries.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+34.38%	693B
NOVO NORDISK A/S	+29.39%	584B
JOHNSON & JOHNSON	-2.95%	372B
MERCK & CO., INC.	+20.61%	332B
ABBVIE INC.	+6.66%	294B
ASTRAZENECA PLC	+14.11%	239B
ROCHE HOLDING AG	-3.03%	211B
NOVARTIS AG	+10.02%	210B
AMGEN INC.	+8.85%	168B

Other Pharmaceuticals